159.75
1.27%
2.00
After Hours:
159.75
Icu Medical Inc stock is traded at $159.75, with a volume of 242.90K.
It is up +1.27% in the last 24 hours and down -9.01% over the past month.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
See More
Previous Close:
$157.75
Open:
$158.54
24h Volume:
242.90K
Relative Volume:
0.96
Market Cap:
$3.87B
Revenue:
$2.30B
Net Income/Loss:
$-70.79M
P/E Ratio:
-136.54
EPS:
-1.17
Net Cash Flow:
$156.90M
1W Performance:
-4.68%
1M Performance:
-9.01%
6M Performance:
+57.11%
1Y Performance:
+89.30%
Icu Medical Inc Stock (ICUI) Company Profile
Name
Icu Medical Inc
Sector
Industry
Phone
949-366-2183
Address
951 CALLE AMANECER, SAN CLEMENTE, CA
Compare ICUI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
ICUI
Icu Medical Inc
|
159.75 | 3.87B | 2.30B | -70.79M | 156.90M | -1.17 |
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Icu Medical Inc Stock (ICUI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-14-24 | Initiated | Jefferies | Hold |
Jun-21-24 | Initiated | Needham | Hold |
Jun-17-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
Nov-08-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
Mar-31-20 | Upgrade | CJS Securities | Market Perform → Market Outperform |
Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Aug-08-19 | Downgrade | Raymond James | Strong Buy → Outperform |
Oct-17-17 | Initiated | KeyBanc Capital Mkts | Sector Weight |
Jun-20-17 | Downgrade | Sidoti | Buy → Neutral |
Mar-11-16 | Initiated | Gabelli & Co | Buy |
Nov-06-15 | Reiterated | ROTH Capital | Buy |
Aug-11-15 | Reiterated | ROTH Capital | Buy |
May-06-15 | Reiterated | ROTH Capital | Buy |
Feb-10-15 | Reiterated | ROTH Capital | Buy |
Nov-11-14 | Upgrade | ROTH Capital | Neutral → Buy |
May-09-13 | Downgrade | The Benchmark Company | Buy → Hold |
Sep-27-12 | Reiterated | The Benchmark Company | Buy |
Apr-12-12 | Initiated | The Benchmark Company | Buy |
Sep-26-11 | Reiterated | Ticonderoga | Buy |
Oct-29-09 | Initiated | C.K. Cooper | Buy |
Oct-08-09 | Initiated | Roth Capital | Hold |
Mar-05-09 | Initiated | Northland Securities | Outperform |
May-02-08 | Initiated | Jesup & Lamont | Buy |
Mar-26-08 | Initiated | Soleil | Buy |
View All
Icu Medical Inc Stock (ICUI) Latest News
Icu medical director David Greenberg sells $153,683 in stock - Investing.com
Icu Medical's COO Christian Voigtlander sells $225,936 in stock - Investing.com
Insider Sell Alert: Christian Voigtlander Sells 9,681 Shares of ICU Medical Inc (ICUI) - GuruFocus.com
Closed Blood Sampling System Market Growth in Future Scope - openPR
ICU Medical COO Christian Voigtlander sells $1.56 million in stock - Investing.com
ICU Medical COO Christian Voigtlander sells $1.56 million in stock By Investing.com - Investing.com South Africa
RSI Alert: ICU Medical (ICUI) Now Oversold - Nasdaq
ICU Medical (FRA:IC7) Future 3-5Y EPS without NRI Growth Ra - GuruFocus.com
ICUI (ICU Medical) Total Assets : $4,305 Mil (As of Sep. 2024) - GuruFocus.com
Segall Bryant & Hamill LLC Lowers Stake in ICU Medical, Inc. (NASDAQ:ICUI) - MarketBeat
ICU Medical, Otsuka team up to boost US IV solutions production - MSN
StockNews.com Upgrades ICU Medical (NASDAQ:ICUI) to Buy - MarketBeat
LMR Partners LLP Invests $3.88 Million in ICU Medical, Inc. (NASDAQ:ICUI) - MarketBeat
Intravenous Solutions Market to Surpass USD 23.96 Billion by 2031 | SkyQuest Technology - Benzinga
ICU Medical Inc (ICUI) Shares Up 1.26% on Nov 19 - GuruFocus.com
ICU Medical, Inc. (NASDAQ:ICUI) Sees Large Decline in Short Interest - MarketBeat
ICU Medical, Inc. (NASDAQ:ICUI) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets - Simply Wall St
State of New Jersey Common Pension Fund D Sells 5,676 Shares of ICU Medical, Inc. (NASDAQ:ICUI) - MarketBeat
Janus Henderson Group's Strategic Reduction in ICU Medical Inc H - GuruFocus.com
GSA Capital Partners LLP Increases Stake in ICU Medical, Inc. (NASDAQ:ICUI) - MarketBeat
ICU Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Earnings call: ICU Medical sees growth amid strategic joint venture By Investing.com - Investing.com Nigeria
Analysis of Fuller & Thaler Asset Management's Recent Transactio - GuruFocus.com
ICU Medical reports revenue of USD 589.1M in Q3 2024 - Medical Buyer
Principal Financial Group Inc. Increases Stake in ICU Medical, Inc. (NASDAQ:ICUI) - MarketBeat
ICU Medical stock hits 52-week high at $193.3 amid robust growth - Investing.com
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America - The Malaysian Reserve
ICU Medical, Otsuka team up to boost US IV solutions production (NASDAQ:ICUI) - Seeking Alpha
ICU Medical (NASDAQ:ICUI) Reaches New 52-Week High Following Better-Than-Expected Earnings - MarketBeat
Earnings call: ICU Medical sees growth amid strategic joint venture - Investing.com
U.S. Intravenous Solutions Market Forecast to Reach $7.91 - GlobeNewswire
U.S. Intravenous Solutions Market Forecast to Reach $7.91 Billion by 2030Industry Analysis with Strategic Profiles of Key Companies; Fresenius Kabi, Pfizer, Baxter, JW Life Science, ICU Medical & More - Yahoo Finance UK
Breaking Down ICU Medical: 4 Analysts Share Their Views - Benzinga
Japan's Otsuka Pharma & ICU Medical sign $200 M deal to create joint venture in North America for manufacturing IV solutions - BSA bureau
Otsuka and ICU Medical forge IV manufacturing network to supply the US - Endpoints News
ICU Medical, Inc. (NASDAQ:ICUI) Q3 2024 Earnings Call Transcript - Insider Monkey
ICU Medical (NASDAQ:ICUI) Receives Hold Rating from Needham & Company LLC - MarketBeat
ICUI (ICU Medical) 14-Day RSI : 53.95 (As of Nov. 13, 2024) - GuruFocus.com
ICU Medical: Q3 Earnings Snapshot - Darien Times
ICU Medical (ICUI) Tops Q3 Earnings and Revenue Estimates - MSN
ICU Medical Inc (ICUI) Q3 2024 Earnings Call Highlights: Strong - GuruFocus.com
ICU Medical Inc (ICUI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
ICU's Joint Venture With Otsuka Should Help Improve Its Margin Profile - Morningstar
ICU Medical Reports Q3 2024 Financial Results - TipRanks
ICU Medical earnings beat by $0.34, revenue topped estimates - Investing.com
ICU Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
ICU Medical, Otsuka Pharmaceutical Factory form joint venture - TipRanks
ICU Medical Inc (ICUI) Q3 2024 Earnings: Revenue Surpasses Estim - GuruFocus.com
ICU Medical Announces Third Quarter 2024 Results and Updates Its Fiscal Year 2024 Guidance - StockTitan
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America – Company Announcement - Financial Times
Icu Medical Inc Stock (ICUI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):